Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Epic Pharma, LLC

China Investment Roundup: A Summer Of Cross-Border Transactions

It was a busy summer for Chinese pharmaceutical companies and investors who went global shopping, eying mega acquisition deals since China announced plans to accept overseas clinical trial data and global multicenter studies as part of its policies.

BioPharmaceutical China

Deals In Depth: March 2016

Sanofi signed a $2bn deal with DiCE Molecules to develop small molecules against targets previously addressed by biologics; Toshiba sold its diagnostics and medical imaging division to Canon for $6bn. Debt offerings dominated biopharma and device financings.

BioPharmaceutical Medical Device

New China Innovation Policies Having Unintended Consequences?

Recent media coverage of “failed” drugs being given a second life in China has raised a raft of issues, including whether preference should be given to the domestic industry, with its poor quality record and scant innovation, and if the impact of the recent official redefinition of a new drug is really spurring innovation or just driving new types of licensing deals.

BioPharmaceutical China

Wuhan Humanwell Goes To America With $550m Epic Buy

One stone, three birds is what Humanwell aims for when the aspiring Chinese specialty pharma gains an entry to the U.S. market via acquisition of Epic Pharma. As a company little known outside China making its first international move, it hopes to gain access to a large product portfolio, exposure to the world's largest pharma market and upgrading its own manufacturing quality.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Distributors
  • Services
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release